Elena M. van Leeuwen-Segarceanu

Convalescent Plasma for COVID-19. A randomized clinical trial

Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel et al. · 2020 · 237 citations · Full text

Vaccination, Immunohematology, Structured Abstract +14

Results of the Phase III Randomized Iskia Trial: Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Lenalidomide-Dexamethasone As Pre-Transplant Induction and Post-Transplant Consolidation in Newly Diagnosed Multiple Myeloma Patients

Francesca Gay, Wilfried Roeloffzen, Meletios Α. Dimopoulos et al. · Blood · 2023 · 96 citations

Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± Chemotherapy

Jesse M. Bijl, Marleen M. Roos, Elena M. van Leeuwen-Segarceanu et al. · The American Journal of Cardiology · 2015 · 57 citations

Lymphoid Neoplasia, Oncology, Lymphoma Treated +5

Comparison of two instruments measuring carotid-femoral pulse wave velocity: Vicorder versus SphygmoCor

Elena M. van Leeuwen-Segarceanu, W. F. Tromp, Willem Jan W. Bos et al. · Journal of Hypertension · 2010 · 51 citations

Progressive Muscle Atrophy and Weakness After Treatment by Mantle Field Radiotherapy in Hodgkin Lymphoma Survivors

Elena M. van Leeuwen-Segarceanu, Lucille D.A. Dorresteijn, Sigrid Pillen et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 41 citations

Radiation Therapy, Mantle Field Radiotherapy, Radiation Oncology +4